SS
ABBV icon

SBI Securities’s AbbVie ABBV Stock Holding History

SBI Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Buy
64,155
+2,818
+5% +$625K 0.38% 53
2025
Q4 		$14M Sell
61,337
-844
-1% -$192K 0.36% 52
2025
Q3 		$14.4M Sell
62,181
-1,883
-3% -$383K 0.37% 47
2025
Q2 		$11.9M Buy
64,064
+1,063
+2% +$198K 0.34% 56
2025
Q1 		$13.2M Sell
63,001
-69
-0.1% -$13.4K 0.44% 46
2024
Q4 		$11.2M Buy
+63,070
New +$11.6M 0.35% 52

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SBI Securities's ABBV Position: Q1 2026 in Review

SBI Securities increased its AbbVie (ABBV) stake by 4.6% in Q1 2026, buying an estimated $625K and bringing the position to 64,155 shares worth $13.8M. The position accounts for 0.38% of the portfolio, ranked #53.

SBI Securities first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.4M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • SBI Securities held 64,155 shares of AbbVie worth $13.8M as of Q1 2026.
  • SBI Securities bought 2,818 AbbVie shares in Q1 2026, an estimated $625K.
  • AbbVie made up 0.38% of SBI Securities's portfolio in Q1 2026, its #53 holding.
  • SBI Securities first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's AbbVie position peaked at $14.4M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.